Decoding Secukinumab Injection: A New Precision Treatment Option...

Ajouter une nouvelle offre d'emploi Health

2026-01-27 09:31:46 - Traduire -

Decoding Secukinumab Injection: A New Precision Treatment Option for Immune Inflammatory Diseases

In the field of immune-mediated inflammatory disease (IMID) treatment, the advent of biologic therapies has broken the limitations of traditional approaches and brought renewed hope for recovery to countless patients. As the world’s first fully human monoclonal antibody targeting interleukin-17A (IL-17A) to receive regulatory approval, secukinumab (Cosentyx) injection has...

0 Commentaires 0 Parts 3KB Vue 0 Aperçu